Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2011-01-18
2011-01-18
Wax, Robert A (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C424S400000, C435S219000, C560S051000
Reexamination Certificate
active
07872047
ABSTRACT:
Disclosed is a composition and methods of treating a skin condition. The ester includes an ester and a dermatologically acceptable carrier. The ester is represented by the general formula 1:
REFERENCES:
patent: 4271083 (1981-06-01), Morimoto et al.
patent: 4407757 (1983-10-01), Morimoto et al.
patent: 6756045 (2004-06-01), Neudecker et al.
patent: 2004/0197282 (2004-10-01), Neudecker et al.
patent: 2005/0175559 (2005-08-01), DiNardo et al.
patent: 2005/0197407 (2005-09-01), DiNardo et al.
patent: 1 449 511 (2004-08-01), None
patent: 1 702 614 (2006-09-01), None
patent: WO 2005/070370 (2005-08-01), None
patent: WO 2009/202586 (2009-02-01), None
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration date of mailing Jan. 26, 2009 received in International Patent Application No. PCT/US2008/009386.
Pignatello, R. et al.; “A calorimetric evaluation of the interaction of amphiphilic prodrugs of idebenone with a biomembrane model”; Journal of Colloid and Interface Science; 299; (2006); pp. 626-635.
Yu, C. A. et al.; “Syntheses of Biologically Active Ubiquinone Derivatives”; Biochemistry; 21; 1982; pp. 4096-4101.
Bartee, S.D. et al.; “Effects of antioxidants on the oxidative stability of oils containing arachidonic, docosapentaaenoic and docosahexaenoic acids”;J Amer Oil Chem Soc; 2007; 84: 363-68.
Demarco et al.,Biochem. Pharmacol.; 2002; 64; 1503-1512.
Kojima, Hajime et al.; “Evaluation of skin irritation in a reconstituted human dermal model (3-D model) using water insoluble fatty acids, fatty alcohols and hydrocarbons”; Altern. Animal Test. Experiment; 1998; pp. 201-210; Volume-Issue No. 5.
McDaniel, D. H. et al.; “Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone”; Journal of Cosmetic Dermatology; 2005; pp. 167-173; Volume-Issue No. 4; Blackwell Publishing.
Narayanan, S. et al.; “Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system”;J Pharm Pharmacol; Aug. 2007; 59(8):1125-30.
Schürer, N. Y.; “Implementation of fatty acid carriers to skin irritation and the epidermal barrier”; Contact Dermatitis; 2002; pp. 199-205; Volume-Issue No. 47; Blackwell Munksgaard; Denmark.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration date of mailing Jun. 26, 2009 received in corresponding International Application No. PCT/US2009/000404.
Co-pending U.S. Appl. No. 11/890,974, filed Aug. 8, 2007, Clendennen and Boaz; now U. S. Publication No. 2009-0042271.
Boaz Neil Warren
Clendennen Stephanie Kay
Al-Awadi Danah
Eastman Chemical Company
Graves, Jr. Bernard J.
Nelson Brett L
Wax Robert A
LandOfFree
Esters of long-chain alcohols and preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters of long-chain alcohols and preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters of long-chain alcohols and preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2698666